Researchers developed an innovative approach -- demonstrated in mouse models and isolated human brain tissue -- to safely and effectively deliver therapeutics into the brain, providing new possibilities for treating a wide range of neurological and psychiatric diseases. The study introduces a first-of-its-kind blood-brain barrier-crossing conjugate (BCC) system, designed to overcome the protective barrier that typically blocks large biomolecules from reaching the central nervous system (CNS).
source https://www.sciencedaily.com/releases/2024/11/241125125221.htm
Qualcomm, Nvidia ready for 'AI-native' 6G, if only the world knew what it
was
-
Meanwhile, formal 6G specs are still in the works
It seems like just yesterday that the 5G rollout started. Now, at Mobile
World Congress, major companies...
5 hours ago
Welcome to the 'The Fact Factory' friends. Its an interesting Hot Spot which brings to you amazing and little known facts from all over the world. So, sit back, take a tour around the world and enjoy the trivia.
No comments:
Post a Comment